ADULT patients with type 1 diabetes should use continuous blood glucose monitoring (CBGM)devices to manage their blood glucose levels, the Endocrine Society has recommended in a new Clinical Practice Guideline, describing CBGM as the gold standard of care - CLICK HERE to access the new guideline.
The US Food and Drug Administration (FDA) yesterday approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device for continuous BGM.
Visit www.fda.gov for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Oct 16